Images List Premium Download Classic

Bowel

Bowel-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Miniature implantable neurostimulator system for sciatic nerves and their branches
Nine Continents Medical, Inc.
June 14, 2018 - N°20180161576

This application describes a miniature implantable neurostimulator system for sciatic nerves and their branches. The implanted miniature neurostimulator is implanted in the leg and stimulates these nerves for the treatment of urinary or bowel incontinence.
Use of anti-cgrp antibodies and antibody fragments to treat diarrhea in subjects with diseases or ...
The University Of Iowa Research Foundation
June 14, 2018 - N°20180161434

The present invention is directed to methods for treating diarrhea, both chronic or acute forms, by the administration of a therapeutically or prophylactically effective amount of antibodies and fragments thereof having binding specificity for cgrp. In particular the methods prevent or reduce diarrhea in conditions or treatments resulting in elevated cgrp levels, e.g., in the gi tract (colon) that ...
Nanoveson(tm): treatment, biomarkers and diagnostic tests for liver diseases and comorbid disease
Nanoveson Llc
June 07, 2018 - N°20180156829

A method of treatment of liver diseases and comorbid diseases is disclosed wherein an oral dose of lipids in an amount effective to trigger the release of cholecystokinin (cck) into the duodenum to generate a major release of bile phospholipids from remodeled stores of triglycerides (tag) in the liver, is administered to a patient in need thereof, thereby causing the ...
Bowel Patent Pack
Download 226+ patent application PDFs
Bowel Patent Applications
Download 226+ Bowel-related PDFs
For professional research & prior art discovery
inventor
  • 226+ full patent PDF documents of Bowel-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Compositions for fecal floral transplantation and methods for making and using them and device for ...
Crestovo Holdings Llc
June 07, 2018 - N°20180153943

This application provides compositions, e.g., formulations, used for gastric, gastrointestinal and/or colonic treatments, and methods for making, storing and using them, including storage, including long term storage, at ambient temperature. Compositions provided herein are useful for treating various diseases or conditions such as autism spectrum disorder, crohn's disease, ulcerative colitis, irritable bowel syndrome, and recurrent or primary c.
Compositions and methods for induction of remission of inflammatory bowel diseases
Kalmarna Limited
June 07, 2018 - N°20180153841

The present invention discloses compositions which comprises steviol glycoside, citric acid monohydrate, monosodium glutamate and/or glycine. Furthermore, the invention provides diets, nutraceuticals and nutrition oral rehydration therapy, means and methods useful in treating and inducing of remission of inflammation in ibd patients..
Methods relating to the treatment of colitis and inflammatory bowel disease
Children's Medical Center Corporation
May 31, 2018 - N°20180147265

The methods and compositions described herein relate to the treatment of bowel inflammation, e.g., ibd or a thrombosis, ischemia, and/or pulmonaryembolism associated with ibd by administering adamts13 to a subject.. .
Bowel Patent Pack
Download 226+ patent application PDFs
Bowel Patent Applications
Download 226+ Bowel-related PDFs
For professional research & prior art discovery
inventor
  • 226+ full patent PDF documents of Bowel-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Novel compounds as rearranged during transfection (ret) inhibitors
Glaxosmithkline Intellectual Property Development Limited
May 31, 2018 - N°20180147194

This invention relates to novel compounds which are inhibitors of the rearranged during transfection (ret) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of gastrointestinal sensitivity, motility and/or secretion and/or abdominal disorders or diseases and/or treatment related to diseases related to ...
Use of andrographolide derivatives in preparation of medicaments for preventing and treating inflammatory bowel diseases
Guangzhou Magpie Pharmaceuticals Co., Ltd.
May 31, 2018 - N°20180147181

The present invention provides uses of an andrographolide derivative in preparation of a medicament for preventing and treating inflammatory bowel disease. The andrographolide derivative al-1 has the mechanisms, for the treatment of ulcerative colitis, of scavenging of free radicals, inhibition of nf-κb signaling pathway activation and cox-2 expression, activation of ppar-γ expression, and thus can ...
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
Corixa Corporation
May 24, 2018 - N°20180142001

Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (ibd), including crohn's disease and ulcerative colitis, are disclosed. Illustrative compositions comprise one or more bacterial polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and t cells that are specific for cells expressing such polypeptides.
Compositions and methods for delivering therapeutic agents into the colon
The Board Of Trustees Of The Leland Stanford Junior University
May 24, 2018 - N°20180140619

Enema compositions containing corticosteroids or salicylic acid derivatives are disclosed. The compositions are liquid at room temperature but turn to gels at body temperature.
Metabolically programmed metal chelators and uses thereof
University Of Florida Research Foundation, Incorporated
May 24, 2018 - N°20180140581

The present invention provides compounds of formula (i), which are “metabolically programmed” metal chelators, e.g., lipophilic, absorbable (e.g., orally absorbable), and effective metal chelators that are converted in vivo to their hydrophilic, nontoxic metabolites. The present invention also provides compounds of formula (ii), which are also “metabolically programmed” metal chelators.
Pathway specific assays for predicting irritable bowel syndrome diagnosis
Nestec S.a.
May 17, 2018 - N°20180136233

The present invention provides antibodies and methods for preparing antibodies to metabolites in the serotonin, tryptophan, kynurenine pathways. The prepared antibodies have low cross-reactivity to related metabolites, and are useful reagents for specific and sensitive immunoassays the present invention also provides stable derivatives of various metabolites and short chain fatty acids.
Inhibition of gliadin peptides
Alba Therapeutics Corporation
May 17, 2018 - N°20180134750

Novel compounds and methods for the inhibition of biological barrier permeability and for the inhibition of peptide translocation across biological barriers are identified. Assays for determining modulators of biological barrier permeability and for peptide translocation across biological barriers are provided.
Bowel Patent Pack
Download 226+ patent application PDFs
Bowel Patent Applications
Download 226+ Bowel-related PDFs
For professional research & prior art discovery
inventor
  • 226+ full patent PDF documents of Bowel-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Antigen-binding proteins that antagonize leptin receptor
Regeneron Pharmaceuticals, Inc.
May 10, 2018 - N°20180127508

The present invention provides antibodies and antigen-binding fragments of antibodies that bind to leptin receptor (lepr), and methods of using the same. According to certain embodiments, the invention includes antibodies and antigen-binding fragments of antibodies that bind lepr and antagonize lepr signaling.
Novel cholesterol metabolite, 5-cholesten, 3beta-25-diol, disulfate (25hcds) for therapy of metabolic disorders, hyperlipidemia, diabetes, ...
Virginia Commonwealth University
May 10, 2018 - N°20180127457

5-cholesten, 3β,25-diol, disulfate (25hcds) has been found to be an authentic pparγ agonist and lxr antagonist, and is used for the therapy of lipid disorders and inflammatory diseases, including without limitation fatty liver, inflammatory bowel, and atherosclerotic diseases.. .
Compounds
May 10, 2018 - N°20180127405

And salts thereof are kmo inhibitors and may be useful in the treatment of various disorders, for example acute pancreatitis, chronic kidney disease, acute kidney disease, acute kidney injury, other conditions associated with systemic inflammatory response syndrome (sirs), huntington's disease, alzheimer's disease, spinocerebellar ataxias, parkinson's disease, aids-dementia complex, hiv infection, amylotrophic lateral sclerosis (als), depression, schizophrenia, sepsis, cardiovascular shock, severe ...
Use of antibiotics with specific therapeutic activities combined with the simultaneous use of lactobacilli and/...
Probiotical S.p.a.
May 10, 2018 - N°20180125902

The present invention relates to the use of antibiotics with specific therapeutic activities combined with the simultaneous use of lactobacilli and/or bifidobacteria having a non-transferable antibiotic resistance and with the same therapeutic indication as said antibiotics. In particular, the present invention relates to a composition comprising or, alternatively, consisting of antibiotics suitable for the treatment of acute and chronic ...
Probiotic compositions for improving metabolism and immunity
New York University
May 10, 2018 - N°20180125900

The application relates to methods based on modulating mammalian intestinal microbiota and related probiotic and prebiotic compositions. Specifically, the application relates to the use of novel bacterial genera ileibacterium and dubosiella, including their species i.
Neuromodulation device
Academisch Medisch Centrum
May 03, 2018 - N°20180117319

The invention provides devices, apparatuses, systems and methods for treating and ameliorating inflammation of the gut. In particular, the invention provides devices, apparatuses and methods in which a neuromodulatory signal is delivered a splenic nerve and/or superior mesenteric plexus (smp).
Porous silicon microparticle-based cancer vaccines and methods for potentiating anti-tumor immunity
The Methodist Hospital
May 03, 2018 - N°20180117176

Porous silicon (psi) microparticles (psm) are disclosed, which provide an important advance in the area of cancer immunotherapeutics and molecular nanomedicine. In particular, potent psm-based adjuvants are disclosed for dendritic cell-based vaccines compositions, and methods for their use in a variety of cancer immunotherapies.
Methods and compositions for bowel cleansing before a medical procedure
The General Hospital Corporation
May 03, 2018 - N°20180117079

Described are kits, food compositions and methods for cleaning the bowel, e.g., in preparation for a medical procedure, e.g., a diagnostic or treatment procedure, such as an endoscopic or surgical procedure, or radiologic imaging such as ct colography.. .
Loading